Preview

Problems of Endocrinology

Advanced search

Screening for diabetic complications as a tool for the evaluation of medical and preventive aid to patients

https://doi.org/10.14341/probl20105613-8

Abstract

The objective of this work was to study the actual prevalence of diabetes mellitus complications and evaluate the quality of health care provided to the patients with these problems in different regions of Russia. A random sample of 11 240 patients with diabetes mellitus (DM) was obtained from a total of 20 regions of the Russian Federation. The study protocol included evaluation of visual function, the state of peripheral nervous system and lower extremities, renal and cardiovascular functions; in addition, HbA1c, creatinine, total cholesterol and triglyceride levels were measured along with albuminuria. It was found that the actual prevalence of major diabetic complications is 20-50% higher than the registered one. The overwhelming majority of the patients were shown to be chronically decompensated. This finding holds for 85.5% of the children, 92.6% of the adolescents, 83.9% and 74.8% of the adult patients with types 1 and 2 DM respectively. The HbA1c level in patients living in rural areas was 33.7-42.1% higher than in residents of regional urban centres. Fewer than 14.4% and 0.6% of the patients with type 2 DM used insulin and its analogs respectively. Overall, the study demonstrated rather poor quality of medical and preventive aid provided to diabetic patients and the necessity of its improvement.

References

1. Дедов И.И., Шестакова М.В. Сахарный диабет M 2003; 76-78.

2. Santos Bueso E., Fernández-Vigo J., Fernández Pérez C. et al. Arch Soc Esp Oftalmol 2005; 80: 3: 187-194.

3. Teruel Maicas C., Fernández-Real J.M., Ricart W. et al. Arch Soc Esp Oftalmol 2005; 80: 2: 85-91.

4. Wong T.Y., Klein R., Islam F.M. et al. Am J Ophthalmol 2006; 141: 3: 446-455.

5. Manaviat M.R., Afkhami M., Shoja M.R. BMC Ophthalmol 2004; 4: 9.

6. Spijkerman A.M.W., Dekker J.M., Nijpels G. et al. Diabetes Care 2003; 26: 2604-2608.

7. Tung T.H., Liu J.H., Lee F.L. et al. Jpn J Ophthalmol 2006; 50: 1: 44-52.

8. Abidi S.M., Negrete H.O., Zahid I. et al. Nephrology (Carlton) 2005; 10: 3: 291-295.

9. Jones C.A., Krolewski A.S., Rogus J. et al. Kidney Int 2005; 67: 5: 1684-1691.

10. Tapp R.J., Shaw J.E., Harper C.A., Balkau B. et al. Diabetes Care 2003; 26: 1731-1737.

11. Donnelly R., Emslie-Smith A.M., Gardner I.D., Morris A.D. Br Med J 2000; 320: 1062-1066.

12. Bacci S., Villella A., Langialonga T. et al. Eur J of Endocrinol 2002; 147: 649-654.

13. Romon I., Fosse S., Eschwege E. et al. Diabetes Metab 2008; 34: 2: 140-147.

14. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). Exp Clin Endocrinol Diabetes 2007; 115: 8: 495-501.

15. Suntsov Y.I., Maslova O.V., Bolotskay L.L. et al. Federation. 67th scientific sessions 2007; 937: 245.


Review

For citations:


Suntsov I.I., Maslova O.V., Dedov I.I. Screening for diabetic complications as a tool for the evaluation of medical and preventive aid to patients. Problems of Endocrinology. 2010;56(1):3-8. https://doi.org/10.14341/probl20105613-8

Views: 546


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)